Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7708711 Ocular implant with therapeutic agents and methods thereof

Patent 7708711 was granted and assigned to Glaukos Corporation on May, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Glaukos Corporation
Glaukos Corporation
0
Date Filed
November 12, 2003
0
Date of Patent
May 4, 2010
0
Patent Application Number
10706300
0
Patent Citations Received
‌
US Patent 11992551 Implants with controlled drug delivery features and methods of using same
0
‌
US Patent 12115102 Ophthalmic implant for delivering therapeutic substances
0
‌
US Patent 12108225 Implantable device for sustained release of a macromolecular drug compound
0
‌
US Patent 11786402 Glaucoma treatment device
‌
US Patent 11690807 Implantable device for sustained release of a macromolecular drug compound
0
‌
US Patent 11744458 Gonioscopes
‌
US Patent 12090291 Endovascular cerebrospinal fluid shunt
0
‌
US Patent 11690806 Implantable device for sustained release of a macromolecular drug compound
0
‌
US Patent 11925578 Drug delivery implants with bi-directional delivery capacity
0
‌
US Patent 11938059 Intraocular shunt insertion techniques
0
•••
Patent Inventor Names
Gregory Smedley
0
Barbara Niksch
0
David Haffner
0
Hosheng Tu
0
Morteza (Mory) Gharib
0
Olav B. Bergheim
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7708711
0
Patent Primary Examiner
‌
Leslie R Deak
0

Find more entities like US Patent 7708711 Ocular implant with therapeutic agents and methods thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo